ID

2158

Descripción

S0023 LUNG CARCINOMA FOLLOW UP FORM S0023: Combination Chemo Plus RT With or Without Gefitinib in Treating Patients With Unresectable Stage III NSCLC Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=9CB6D1D2-A964-34E4-E034-080020C9C0E0

Link

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=9CB6D1D2-A964-34E4-E034-080020C9C0E0

Palabras clave

Versiones (3)
  1. 19/9/12 19/9/12 -
  2. 28/5/15 28/5/15 -
  3. 3/6/15 3/6/15 -
Subido en

19 de septiembre de 2012

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0 Legacy
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Lung Cancer NCT00020709 Follow-Up - S0023 LUNG CARCINOMA FOLLOW UP FORM - 2030090v3.0

Inglés

No Instruction available.

1 formularios  
  1. StudyEvent: S0023 LUNG CARCINOMA FOLLOW UP FORM
    1. No Instruction available.
Unnamed1
Descripción

Unnamed1

SWOG Patient ID
Descripción

SWOGPatientID

Tipo de datos

text

SWOG Study No.
Descripción

SWOGStudyNo.

Tipo de datos

text

Registration Step
Descripción

RegistrationStep

Tipo de datos

text

Alias
NCI Thesaurus ValueDomain
C25337
UMLS 2011AA ValueDomain
C0237753
NCI Thesaurus ValueDomain
C16154
UMLS 2011AA ValueDomain
C1704379
Patient Initials (L, F,M)
Descripción

PatientInitials

Tipo de datos

text

Institution / Affiliate
Descripción

Institution/Affiliate

Tipo de datos

text

Physician
Descripción

Physician

Tipo de datos

text

Group Name (Groups other than SWOG )
Descripción

GroupName

Tipo de datos

text

Study No. (Groups other than SWOG )
Descripción

StudyNo.

Tipo de datos

double

Pt. ID (Groups other than SWOG )
Descripción

Pt.ID

Tipo de datos

text

Vital Status
Descripción

Vital Status

Vital Status
Descripción

VitalStatus:

Tipo de datos

text

Date of last contact or death (If vital status is Dead, complete and submit Notice of Death form.)
Descripción

Dateoflastcontactordeath:

Tipo de datos

text

Disease Follow Up Status
Descripción

Disease Follow Up Status

Has the patient had a documented clinical assessment for this cancer since submission of the previous follow-up form?
Descripción

Hasthepatienthadadocumentedclinicalassessmentforthiscancersincesubmissionofthepreviousfollow-upform?

Tipo de datos

text

If Yes, Date of Last Clinical Assessment
Descripción

IfYes,DateofLastClinicalAssessment:

Tipo de datos

text

Has the patient developed a first relapse or progression that has not been previously reported?
Descripción

Hasthepatientdevelopedafirstrelapseorprogressionthathasnotbeenpreviouslyreported?

Tipo de datos

text

If Yes, Date of Relapse or Progression
Descripción

IfYes,DateofRelapseorProgression:

Tipo de datos

text

If yes, please submit the Lung Carcinoma First Site(s) of Progression or Relapse Form.
Descripción

Ifyes,pleasesubmittheLungCarcinomaFirstSite(s)ofProgressionorRelapseForm.

Tipo de datos

text

Notice Of New Primary
Descripción

Notice Of New Primary

Has a new primary cancer or myelodysplastic syndrome (MDS) been diagnosed that has not been previously reported?
Descripción

Hasanewprimarycancerormyelodysplasticsyndrome(MDS)beendiagnosedthathasnotbeenpreviouslyreported?

Tipo de datos

text

If Yes, Date of Diagnosis
Descripción

IfYes,DateofDiagnosis:

Tipo de datos

text

New Primary Site
Descripción

NewPrimarySite:

Tipo de datos

text

Non-protocol Treatment
Descripción

Non-protocol Treatment

Has the patient received any non-protocol cancer therapy (prior to progression/relapse) not previously reported?
Descripción

Hasthepatientreceivedanynon-protocolcancertherapy(priortoprogression/relapse)notpreviouslyreported?

Tipo de datos

text

If Yes, Date of First Non-Protocol Therapy
Descripción

IfYes,DateofFirstNon-ProtocolTherapy:

Tipo de datos

text

Agents
Descripción

Agents:

Tipo de datos

text

Long Term Toxicity
Descripción

Long Term Toxicity

Has the patient experienced (prior to treatment for progression or relapse or a second primary, and prior to non-protocol treatment) any severe (grade =>3) long term toxicity that has not been previously reported?
Descripción

Hasthepatientexperienced(priortotreatmentforprogressionorrelapseorasecondprimary,andpriortonon-protocoltreatment)anysevere(grade=>3)longtermtoxicitythathasnotbeenpreviouslyreported?

Tipo de datos

text

If Yes, Toxicities and Grades
Descripción

IfYes,ToxicitiesandGrades:

Tipo de datos

text

Notes
Descripción

Notes

Notes
Descripción

Notes

Tipo de datos

text

Volver a la parte superior de la página

Similar models

No Instruction available.

1 formularios
  1. StudyEvent: S0023 LUNG CARCINOMA FOLLOW UP FORM
    1. No Instruction available.
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Unnamed1
SWOGPatientID
Item
SWOG Patient ID
text
SWOGStudyNo.
Item
SWOG Study No.
text
RegistrationStep
Item
Registration Step
text
C25337 (NCI Thesaurus ValueDomain)
C0237753 (UMLS 2011AA ValueDomain)
C16154 (NCI Thesaurus ValueDomain)
C1704379 (UMLS 2011AA ValueDomain)
PatientInitials
Item
Patient Initials (L, F,M)
text
Institution/Affiliate
Item
Institution / Affiliate
text
Physician
Item
Physician
text
GroupName
Item
Group Name (Groups other than SWOG )
text
StudyNo.
Item
Study No. (Groups other than SWOG )
double
Pt.ID
Item
Pt. ID (Groups other than SWOG )
text
Item Group
Vital Status
Item
Vital Status
text
CL.1
Code List
Vital Status
CL Item
Alive (Alive)
CL Item
Dead (Dead)
Dateoflastcontactordeath:
Item
Date of last contact or death (If vital status is Dead, complete and submit Notice of Death form.)
text
Item Group
Disease Follow Up Status
Item
Has the patient had a documented clinical assessment for this cancer since submission of the previous follow-up form?
text
CL.2
Code List
Has the patient had a documented clinical assessment for this cancer since submission of the previous follow-up form?
CL Item
No (No)
CL Item
Yes (Yes)
IfYes,DateofLastClinicalAssessment:
Item
If Yes, Date of Last Clinical Assessment
text
Item
Has the patient developed a first relapse or progression that has not been previously reported?
text
CL.3
Code List
Has the patient developed a first relapse or progression that has not been previously reported?
CL Item
No2007229 (No)
CL Item
Yes2007230 (Yes)
IfYes,DateofRelapseorProgression:
Item
If Yes, Date of Relapse or Progression
text
Ifyes,pleasesubmittheLungCarcinomaFirstSite(s)ofProgressionorRelapseForm.
Item
If yes, please submit the Lung Carcinoma First Site(s) of Progression or Relapse Form.
text
Item Group
Notice Of New Primary
Item
Has a new primary cancer or myelodysplastic syndrome (MDS) been diagnosed that has not been previously reported?
text
CL.4
Code List
Has a new primary cancer or myelodysplastic syndrome (MDS) been diagnosed that has not been previously reported?
CL Item
No2007235 (No)
CL Item
Yes2007236 (Yes)
IfYes,DateofDiagnosis:
Item
If Yes, Date of Diagnosis
text
NewPrimarySite:
Item
New Primary Site
text
Item Group
Non-protocol Treatment
Item
Has the patient received any non-protocol cancer therapy (prior to progression/relapse) not previously reported?
text
CL.5
Code List
Has the patient received any non-protocol cancer therapy (prior to progression/relapse) not previously reported?
CL Item
No2007241 (No)
CL Item
Yes2007242 (Yes)
IfYes,DateofFirstNon-ProtocolTherapy:
Item
If Yes, Date of First Non-Protocol Therapy
text
Agents:
Item
Agents
text
Item Group
Long Term Toxicity
Item
Has the patient experienced (prior to treatment for progression or relapse or a second primary, and prior to non-protocol treatment) any severe (grade =>3) long term toxicity that has not been previously reported?
text
CL.6
Code List
Has the patient experienced (prior to treatment for progression or relapse or a second primary, and prior to non-protocol treatment) any severe (grade =>3) long term toxicity that has not been previously reported?
CL Item
No2007247 (No)
CL Item
Yes2007248 (Yes)
IfYes,ToxicitiesandGrades:
Item
If Yes, Toxicities and Grades
text
Item Group
Notes
Notes
Item
Notes
text
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial